Wave Life Sciences WVE SG — Deferred Tax Assets Operating Loss Carryforwards

Similar metrics at other companies

TMCSG — Operating Loss Carryforwards

$21.96M+7.9%

NBGB — Operating Loss Carryforwards

$112K+187%

VSATGB — Deferred Tax Assets Operating Loss Carryforwards

$64.2M—

NOVTGB — Deferred Tax Assets Capital Loss Carryforwards

$1M+25.0%

LACCA — Deferred Tax Assets Operating Loss Carryforwards

$16.2M+1.9%

CRSPGB — Deferred Tax Assets Operating Loss Carryforwards Foreign

$2.4M-7.7%

Questions, answered.

What is Wave Life Sciences's SG — deferred tax assets operating loss carryforwards?

Wave Life Sciences (WVE) reported SG — deferred tax assets operating loss carryforwards of $144.8M in Q4 2025.

How has Wave Life Sciences's SG — deferred tax assets operating loss carryforwards changed year-over-year?

Wave Life Sciences's SG — deferred tax assets operating loss carryforwards increased by 9.1% year-over-year, from $132.7M to $144.8M.

What does SG — deferred tax assets operating loss carryforwards mean?

This metric quantifies the value of tax losses that can be carried forward to offset future taxable income within the segment. It represents a potential future tax benefit that is contingent upon the segment achieving future profitability.